These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7760880)

  • 61. Treatment of acute myelogenous leukemia.
    Meisenberg B
    N Engl J Med; 1995 Jun; 332(25):1718; author reply 1718-9. PubMed ID: 7619165
    [No Abstract]   [Full Text] [Related]  

  • 62. [Indications for allogeneic bone marrow transplantation (BMT) in adult acute myelogenous leukemia: matched-pair analysis in comparison with chemotherapy in patients achieving initial remission].
    Sakura T
    Rinsho Ketsueki; 2001 May; 42(5):380-4. PubMed ID: 11452455
    [No Abstract]   [Full Text] [Related]  

  • 63. [Bone marrow transplantation in the treatment of acute leukemias].
    Moiseev SI; Ganapiev AA; Abdulkadyrov KM
    Ter Arkh; 1996; 68(12):8-10. PubMed ID: 9054052
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Why is clinical progress in acute myelogenous leukemia so slow?
    Rowe JM
    Best Pract Res Clin Haematol; 2008 Mar; 21(1):1-3. PubMed ID: 18342806
    [No Abstract]   [Full Text] [Related]  

  • 65. Acute non-lymphoblastic leukemias in childhood.
    Dole MG; Warrier RP; Yu LC
    Indian J Pediatr; 1989; 56(6):683-92. PubMed ID: 2700561
    [No Abstract]   [Full Text] [Related]  

  • 66. Uncertainties in the standard care of acute myelogenous leukemia.
    Rowe JM
    Leukemia; 2001 Apr; 15(4):677-9. PubMed ID: 11368379
    [No Abstract]   [Full Text] [Related]  

  • 67. Acute myelogenous leukaemia.
    Pinto A; Zulian GB; Archimbaud E
    Crit Rev Oncol Hematol; 1998 Feb; 27(2):161-4. PubMed ID: 9571323
    [No Abstract]   [Full Text] [Related]  

  • 68. Treatment of acute myelogenous leukemia.
    Ghaddar H; Anderlini P; Estey E
    N Engl J Med; 1995 Jun; 332(25):1717-8; author reply 1718-9. PubMed ID: 7760880
    [No Abstract]   [Full Text] [Related]  

  • 69. [Current situation and perspective for treatment of acute myelogenous leukemia in adults].
    Fukushima T; Ueda T
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):295-302. PubMed ID: 9492819
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treatment of acute myelogenous leukaemia.
    Löwenberg B
    J Intern Med Suppl; 1997; 740():17-22. PubMed ID: 9350177
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Response in acute myeloid leukemia.
    Estey E
    Clin Adv Hematol Oncol; 2008 Feb; 6(2):113-7. PubMed ID: 18347562
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Histamine dihydrochloride and interleukin-2 in acute myeloid leukemia--background and results.
    Brune M; Romero AI; Hellstrand K
    Inflamm Res; 2009 Apr; 58 Suppl 1():4-8. PubMed ID: 19271134
    [No Abstract]   [Full Text] [Related]  

  • 73. Allogeneic stem cell transplantation in acute myeloid leukemia: a risk-adapted approach.
    Lodewyck T; Cornelissen JJ
    Blood Rev; 2008 Nov; 22(6):293-302. PubMed ID: 18455284
    [TBL] [Abstract][Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.